Number of the records: 1
Assessment of adiponectin and clinical and metabolic risk factors in patients with NAFLD and metabolic syndrome
SYS 0190171 LBL 00000naa^^22^^^^^^^^450 005 20230727120823.0 100 $a 20230727d2018 m y0sloy0103 ba 101 0-
$a eng 102 $a PL 200 1-
$a Assessment of adiponectin and clinical and metabolic risk factors in patients with NAFLD and metabolic syndrome $f Kupčová V. ... [et al.] 303 $a Popis urobený z citácie 463 -1
$1 200 1 $a Clin Exp Hepatol $v Suppl. 1 (2018), s. 27-28 701 -1
$3 sllk_un_auth*p0028679 $a Kupčová $b Viera $f 1951- $p 3. interná klinika LF UK a FNsP Bratislava, Nemocnica akademika L. Dérera, Bratislava $4 070 701 -1
$3 sllk_un_auth*p0020569 $a Muchová $b Jana $f 1951- $p Ústav lekárskej chémie, biochémie a klinickej biochémie LFUK, Bratislava $4 070 701 -1
$3 sllk_un_auth*p0061054 $a Bulas $b Jozef $p 1. interná klinika LF UK a UN Bratislava $4 070 701 -1
$3 sllk_un_auth*0026797 $a Potočárová $b Mária $p 1. interná klinika LFUK a UNB, Bratislava $4 070 701 -1
$3 sllk_un_auth*0023010 $a Fedelešová $b Michaela $p 3. interná klinika LF UK a Nemocnica akad. L. Dérera UN Bratislava $4 070 701 -1
$3 sllk_un_auth*p0004460 $a Turecký $b Ladislav $f 1953- $p Ústav lekárskej chémie, biochémie a klinickej biochémie LF UK, Bratislava $4 070 801 -0
$a SK $b BA006 $c 20230727 $g AACR2
Number of the records: 1